Onkologie. 2023:17(1):47-50 | DOI: 10.36290/xon.2023.011

Nevoid melanoma as a diagnostic problem

Paula Ďuríková
Dermatovenerologická klinika Lekárskej fakulty Univerzity Komenského a Univerzitnej nemocnice Bratislava

Nevoid melanoma is one of the most difficult types of malignant melanoma to diagnose. Most often, it is clinically and histopathologically similar to the common intradermal and compound melanocytic nevus. This rare lesion defies conventional ideas about the morphology of malignant melanocytic neoplasm. It is an aggressive tumor. Its poor prognosis is in contrast to its organized architecture, which resembles a banal benign lesion. A significant part of the diagnostic process in cases of melanocytic neoplasms is based on the subjective assessment of the lesions. Therefore, increasing awareness of this rare type of malignant melanoma can aid decision-making in cases of interpretative uncertainties.

Keywords: nevoid melanoma, dermoscopy, histopathology, melanocytic nevus.

Accepted: February 22, 2023; Published: March 1, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ďuríková P. Nevoid melanoma as a diagnostic problem. Onkologie. 2023;17(1):47-50. doi: 10.36290/xon.2023.011.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Crowson AN. Medicolegal aspects of Neoplastic Dermatology. Mod Pathol. 2006;19(2):148-154. Go to original source... Go to PubMed...
    2. Tsujimura M, Kaku Y, Yasuhide T, et al. Maturing papillomatous nevoid melanoma in the scalp mimicking recurrent melanocytic nevus: A case report of previously undescribed subtype of nevoid melanoma. Pathol Int. 2022;72(1):59-64. Go to original source... Go to PubMed...
    3. Cabrera R, Recule F. Unusual clinical presentations of malignant melanoma: A review of Clinical and histologic features with special emphasis on dermatoscopic findings. Am J Clin. Dermatol. 2018;19(1):15-23. Go to original source... Go to PubMed...
    4. Elder DE, Massi D, Scolyer R, et al. WHO Classification of Skin Tumours IARC WHO Classification of Tumours, 4th Edition. Lyon: IARC; 2018.
    5. Pampena R, Lai M, Lombardi M, et al. Clinical and dermoscopic features associated with difficult-to-recognize variants of cutaneous melanoma. JAMA Dermatol. 2020;156(4):430-440. Go to original source... Go to PubMed...
    6. Kossard S, Wilkinson B. Small cell (naevoid) melanoma: A clinicopathologic study of 131 cases. Aust J Dermatol. 1997;38(1):54-58. Go to original source... Go to PubMed...
    7. Blessing K, Evans AT, Al-nafussi A. Verrucous naevoid and keratotic malignant melanoma: A Clinico-Pathological Study of 20 cases. Histopathology. 1993;23(5):453-458. Go to original source... Go to PubMed...
    8. Longo C, Piana S, Marghoob A, et al. Morphological features of naevoid melanoma: Results of a multicentre study of the International Dermoscopy Society. Br J Dermatol. 2015;172(4):961-967. Go to original source... Go to PubMed...
    9. Vestergaard ME, Macaskill P, Holt PE, et al. Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: A Meta-analysis of studies performed in a clinical setting. Br J Dermatol. 2008;159(1):669-676. Go to original source... Go to PubMed...
    10. Argenziano G, Briatico G, Brancaccio G, Clinical Clues to Avoid Missing Melanoma When Morphology is Not Enough. Dermatol Pract Concept. 2021;11(4):41-43. Go to original source...
    11. Lee KJ, Soyer PH. Future developments in teledermoscopy and total body photography. Int J Dermatol Venereol. 2019;2(1):15-18.
    12. Argenziano G, Catricalà C, Ardigo M, et al. Seven-point checklist of dermoscopy revisited. Br J Dermatol. 2011;164(4):785-790. Go to original source... Go to PubMed...
    13. Zulauf EE, Connors JC, Hardy MA, et al. Use of fluorescence in situ hybridization for diagnosis of rare Nevoid Melanoma: A case report. FASTRAC. 2021;1(1):1-4. Go to original source...
    14. Massi G, LeBoit PE. Histological diagnosis of Nevi and melanoma. Darmstadt: Springer; 2014. Go to original source...
    15. Martín-Alcalde J, Gamo-Villegas R, Floristán-Muruzábal MU, et al. Nevoid melanoma: Dermoscopic and in vivo reflectance confocal microscopic aspects in 4 cases. JAAD Case Rep. 2021;11(2):132-136. Go to original source... Go to PubMed...
    16. Tinca AC, Friciu C, Niculescu R, et al. Nevoid melanoma - the unique histological and immunohistochemical appearance. Bull Transilv Univ. 2022;15(64):25-32. Go to original source...
    17. Ohsie SJ, Sarantopoulos GP, Cochran AJ, et al. Immunohistochemical characteristics of melanoma. J Cutan Pathol. 2008;35(5):433-444. Go to original source... Go to PubMed...
    18. Mesbah Ardakani N, Singh S, Thomas C, et al. Mitotically active nevus and nevoid melanoma: A Clinicopathological and Molecular Study. Am J Dermatopathol. 2020;43(3):182-190. Go to original source... Go to PubMed...
    19. Koh SS, Lau SK, Roehmholdt B, et al. Immunohistochemistry of p16 in nevi of pregnancy and nevoid melanomas: a clinical follow-up study. J Clin Path. 2021;20:(7). Go to original source... Go to PubMed...
    20. Lohman ME, Steen AJ, Grekin RC, North JP. The utility of PRAME staining in identifying malignant transformation of melanocytic Nevi. J Cutan Pathol. 2021;48(7):856-862. Go to original source... Go to PubMed...
    21. Gassenmaier M, Hahn M, Metzler G, et al. Diffuse PRAME Expression Is Highly Specific for Thin Melanomas in the Distinction from Severely Dysplastic Nevi but Does Not Distinguish Metastasizing from Non-Metastasizing Thin Melanomas. Cancers. 2021;13(15):1-15. Go to original source... Go to PubMed...
    22. North JP, Garrido MC, Kolaitis NA, et al. Fluorescence in situ hybridization as an ancillary tool in the diagnosis of ambiguous melanocytic neoplasms. Am J Surg Pathol. 2014;38(6):824-831. Go to original source... Go to PubMed...
    23. Cook MG, Massi D, Blokx WA, et al. New insights into naevoid melanomas: A clinicopathological reassessment. Histopathol. 2017;71(6):943-950. Go to original source... Go to PubMed...
    24. Salzmann M, Pawlowski J, Loquai C, et al. MEK inhibitors for pre-treated, NRAS-mutated metastatic melanoma: A multi-centre, retrospective study. Eur J Cancer. 2022;166:24-32. Go to original source... Go to PubMed...
    25. McNutt NS, Urmacher C, Hakimian J, et al. Nevoid malignant melanoma: Morphologic patterns and immunohistochemical reactivity. J Cutan Pathol. 1995;22(6):502-517. Go to original source... Go to PubMed...
    26. Garbe C, Amaral T, Peris K, et al. European consensus-based interdisciplinary guideline for melanoma. part 1: Diagnostics: Update 2022. Eur J Cancer. 2022;170:236-255. Go to original source... Go to PubMed...
    27. Zembowicz A, McCusker M, Chiarelli C, et al. Morphological Analysis of nevoid melanoma. Am J Dermatopathol. 2001;23(3):167-175. Go to original source... Go to PubMed...
    28. Sacchetto L, Rosso S, Comber H, et al. Skin melanoma deaths within 1 or 3 years from diagnosis in Europe. Int J Can­cer. 2021;148(12):2898-2905. Go to original source... Go to PubMed...
    29. Wozniak L, Zielinski KW. Skin Tumors-P6231204. In: commons.wikimedia.org [Internet]. 2011 Jun 23. [cited 2022 oct 30]. Available from: https://commons.wikimedia.org/wiki/File:Skin_Tumors-P6231204.jpg (CC BY-SA 3.0) https://creativecommons.org/licenses/by-sa/3.0/legalcode.
    30. Wozniak L, Zielinski KW. Skin Tumors-069.jpg. In: commons.wikimedia.org [Internet]. 2011 Sep 7. [cited 2022 nov 5]. Available from: https://commons.wikimedia.org/wiki/File:Skin_Tumors-069.jpg (CC BY-SA 3.0) https://creativecommons.org/licenses/by-sa/3.0/legalcode.

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.